Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc (WINT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Windtree Therapeutics Inc 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 USA

www.windtreetx.com P: 215-488-9300 F: 215-488-9301

Description:

Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 1,673
Enterprise Value, $K 10,753
Shares Outstanding, K 5,148
Annual Sales, $ 0 K
Annual Net Income, $ -39,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,430 K
EBIT, $ -16,040 K
EBITDA, $ 3,940 K
60-Month Beta 0.63
% of Insider Shareholders 0.81%
% of Institutional Shareholders 21.98%
Float, K 5,106
% Float 99.19%
Short Volume Ratio 0.24

Growth:

1-Year Return -96.06%
3-Year Return -99.87%
5-Year Return -99.96%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 98.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 11/09/23
Latest Earnings Date 04/01/24
Earnings Per Share ttm -20.27
EPS Growth vs. Prev Qtr 47.56%
EPS Growth vs. Prev Year 86.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 02/24/23

WINT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -274.89%
Return-on-Assets % -66.31%
Profit Margin % 0.00%
Debt/Equity 2.07
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.24
Book Value/Share 1.45
Interest Coverage -810.60
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar